Glucosamine has broad development prospects and high market concentration

Glucosamine, referred to as aminosugar, is a compound in which one of the hydroxyl groups of glucose is replaced by an amino group. It is an important precursor in the glycosylation reaction of proteins or lipids, an important nutrient for the formation of chondrocytes, and a natural tissue component of healthy articular cartilage. According to different production processes, glucosamine can be divided into three levels: glucosamine hydrochloride, glucosamine sulfate and glucosamine sulfate.

Glucosamine is mainly divided into glucosamine for health care products and glucosamine for medical use. Among them, glucosamine for health care products has a relatively low technical threshold and loose supervision. The industry has large production capacity and output and many manufacturing companies. The representative companies are mainly in Zhejiang. Jinke Pharmaceutical Co., Ltd., Zhejiang Fengrun Biotechnology Co., Ltd., Zhejiang Aoxing Biotechnology Co., Ltd., Zhejiang Chengyi Pharmaceutical Co., Ltd., Shishi Huabao Marine Biomedicine Co., Ltd., Shandong Runde Biotechnology Co., Ltd., etc. . Glucosamine for medical use has high technical requirements and is strictly supervised by the state. Therefore, there are few companies in the industry. The main companies include Zhejiang Jinshell Pharmaceutical Co., Ltd. and Zhejiang Chengyi Pharmaceutical Co., Ltd.

In recent years, with the improvement of people’s consumption level and the improvement of consumers’ health awareness, the health care product industry is developing rapidly, and various types of health care products are emerging in endlessly. Coupled with the arrival of China’s aging society, the market demand for health care products represented by bone glucosamine has grown rapidly. The application of glucosamine health care products that regulate the central nervous system and reduce allergic symptoms has promoted the continued growth of domestic demand for glucosamine. . According to the “2022-2027 Glucosamine Industry In-depth Market Research and Investment Strategy Suggestions Report released by the Industrial Research Center, in 2021 China’s demand for glucosamine reaches about 6,000 tons.

Industry analysts said that the main production processes of glucosamine include biological extraction and microbial fermentation. Biological extraction is carried out using shrimp and crab shells as raw materials. Production has a large amount of sewage discharge and is difficult to process; microbial fermentation uses corn as the main production raw material, which has low production cost, low sewage discharge, and is easy to process. Therefore, as environmental protection policies become stricter, environmental protection costs increase, and industry competition intensifies, more and more companies will use microbial fermentation to produce glucosamine.